These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11027463

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, Hwang BD, Yoon WH.
    BMC Cancer; 2006 Aug 18; 6():211. PubMed ID: 16916471
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T, Kuester D, Boltze C, Schulz TO, Samii A, Herold C, Ostertag H, Roessner A.
    Hum Pathol; 2008 Feb 18; 39(2):217-23. PubMed ID: 17949787
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH.
    J Rheumatol; 2006 Feb 18; 33(2):311-7. PubMed ID: 16465663
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
    Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E.
    Clin Cancer Res; 2001 Aug 18; 7(8):2396-404. PubMed ID: 11489818
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
    Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N.
    Br J Cancer; 1999 Jan 18; 79(1):40-6. PubMed ID: 10408691
    [Abstract] [Full Text] [Related]

  • 19. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
    Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA.
    Cancer Res; 2004 Oct 01; 64(19):7045-9. PubMed ID: 15466198
    [Abstract] [Full Text] [Related]

  • 20. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
    Knappe UJ, Hagel C, Lisboa BW, Wilczak W, Lüdecke DK, Saeger W.
    Acta Neuropathol; 2003 Nov 01; 106(5):471-8. PubMed ID: 12904990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.